• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife Squalene-based Adjuvants Stimulate CD8 T Cell, but Not Antibody Responses, Through a RIPK3-dependent Pathway

tetano

Editor, Senior Moderator
Elife


. 2020 Jun 9;9:e52687.
doi: 10.7554/eLife.52687. Online ahead of print.
Squalene-based Adjuvants Stimulate CD8 T Cell, but Not Antibody Responses, Through a RIPK3-dependent Pathway


Eui Ho Kim[SUP] 1 [/SUP], Matthew C Woodruff[SUP] 2 [/SUP], Lilit Grigoryan[SUP] 3 [/SUP], Barbara Maier[SUP] 4 [/SUP], Song Hee Lee[SUP] 5 [/SUP], Pratushya Mandal[SUP] 6 [/SUP], Mario Cortese[SUP] 7 [/SUP], Muktha S Natrajan[SUP] 8 [/SUP], Rajesh Ravindran[SUP] 9 [/SUP], Huailiang Ma[SUP] 7 [/SUP], Miriam Merad[SUP] 10 [/SUP], Alexander D Gitlin[SUP] 11 [/SUP], Edward S Mocarski[SUP] 12 [/SUP], Joshy Jacob[SUP] 5 [/SUP], Bali Pulendran[SUP] 3 [/SUP]



Affiliations

Abstract

The squalene-based oil-in-water emulsion (SE) vaccine adjuvant MF59 has been administered to more than 100 million people in more than 30 countries, in both seasonal and pandemic influenza vaccines. Despite its wide use and efficacy, its mechanisms of action remains unclear. In this study we demonstrate that immunization of mice with MF59 or its mimetic AddaVax (AV) plus soluble antigen results in robust antigen-specific antibody and CD8 T cell responses in lymph nodes and non-lymphoid tissues. Immunization triggered rapid RIPK3-kinase dependent necroptosis in the lymph node which peaked at 6 hours, followed by a sequential wave of apoptosis. Immunization with alum plus antigen did not induce RIPK3 kinase-dependent signaling. RIPK3-dependent signaling induced by MF59 or AV was essential for cross-presentation of antigen to CD8 T cells by Batf3-dependent CD8[SUP]+[/SUP] DCs. Consistent with this, RIPK3-kinase deficient or Batf3 deficient mice were impaired in their ability to mount adjuvant-enhanced CD8 T cell responses. However, CD8 T cell responses were unaffected in mice deficient in MLKL, a downstream mediator of necroptosis. Surprisingly, antibody responses were unaffected in RIPK3-kinase or Batf3 deficient mice. In contrast, antibody responses were impaired by in vivo administration of the pan-caspase inhibitor Z-VAD-FMK, but normal in caspase-1 deficient mice, suggesting a contribution from apoptotic caspases, in the induction of antibody responses. These results demonstrate that squalene-based vaccine adjuvants induce antigen-specific CD8 T cell and antibody responses, through RIPK3-dependent and-independent pathways, respectively.

Keywords: immunology; inflammation; mouse.
 
Back
Top Bottom